Survival and growth of cellular grafts in tissue engineering (TE) are limited by the rate of oxygen (O2) and nutrient diffusion. As such, monitoring the levels of nutrients and O2 available to the cells is essential to assess the physiology of the cells and to evaluate strategies aiming at improving nutrient availability. In this article, a reporter system containing the luciferase gene driven by a hypoxia responsive promoter was used to monitor cellular hypoxia in a TE context. We report that luciferase activity correlates with the O2 tension in the cell culture medium. When transgenic cells were seeded onto scaffolds and implanted in immune-deficient mice subcutaneously, luciferase activity was detected. To validate the response to O2 levels of this reporter system, we cultured transgenic cells on biomaterials in a flow perfusion bioreactor and observed that cells in the bioreactor displayed a drastically lower luciferase activity than conventional static culture, and that higher luciferase activity is observed in the interior of a tissue-engineered construct, illustrating the uneven O2 distribution in three-dimensional constructs under conventional static culture. We conclude that this reporter system is a versatile tool to investigate cellular O2 availability in TE both in vitro and in vivo.
Get full access to this article
View all access options for this article.
References
1.
CarmelietP., JainR.K.Angiogenesis in cancer and other diseases. Nature, 407:249. 2000.
2.
GriffithC.K., MillerC., SainsonR.C., CalvertJ.W., JeonN.L., HughesC.C., GeorgeS.C.Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng, 11:257. 2005.
3.
Ishaug-RileyS.L., Crane-KrugerG.M., YaszemskiM.J., MikosA.G.Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials, 19:1405. 1998.
4.
RadisicM., MaldaJ., EppingE., GengW., LangerR., Vunjak-NovakovicG.Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng, 93:332. 2006.
5.
MaldaJ., WoodfieldT.B., van der VloodtF., KooyF.K., MartensD.E., TramperJ., van BlitterswijkC.A., RiesleJ.The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials, 25:5773. 2004.
6.
RivronN.C., LiuJ.J., RouwkemaJ., de BoerJ., van BlitterswijkC.A.Engineering vascularised tissues in vitro. Eur Cell Mater, 15:27. 2008.
7.
DrueckeD., LangerS., LammeE., PieperJ., UgarkovicM., SteinauH.U., HomannH.H.Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A, 68:10. 2004.
8.
MartinI., WendtD., HebererM.The role of bioreactors in tissue engineering. Trends Biotechnol, 22:80. 2004.
9.
WendtD., StroebelS., JakobM., JohnG.T., MartinI.Uniform tissues engineered by seeding and culturing cells in 3D scaffolds under perfusion at defined oxygen tensions. Biorheology, 43:481. 2006.
10.
RouwkemaJ., RivronN.C., van BlitterswijkC.A.Vascularization in tissue engineering. Trends Biotechnol, 26:434. 2008.
RodaA., GuardigliM., PasiniP., MirasoliM.Bioluminescence and chemiluminescence in drug screening. Anal Bioanal Chem, 377:826. 2003.
13.
ChoyG., ChoykeP., LibuttiS.K.Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging, 2:303. 2003.
14.
LukerG.D., LukerK.E.Optical imaging: current applications and future directions. J Nucl Med, 49:1. 2008.
15.
de BoerJ., van BlitterswijkC., LowikC.Bioluminescent imaging: emerging technology for non-invasive imaging of bone tissue engineering. Biomaterials, 27:1851. 2006.
16.
MaldaJ., KleinT.J., UptonZ.The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng, 13:2153. 2007.
ShibataT., GiacciaA.J., BrownJ.M.Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther, 7:493. 2000.
19.
HaradaH., Kizaka-KondohS., ItasakaS., ShibuyaK., MorinibuA., ShinomiyaK., HiraokaM.The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Biochem Biophys Res Commun, 360:791. 2007.
20.
MogfordJ.E., RoyN.K., CrossK.J., MustoeT.A.Use of hypoxia-inducible factor signal transduction pathway to measure O2 levels and modulate growth factor pathways. Wound Repair Regen, 11:496. 2003.
21.
HaradaH., Kizaka-KondohS., HiraokaM.Optical imaging of tumor hypoxia and evaluation of efficacy of a hypoxia-targeting drug in living animals. Mol Imaging, 4:182. 2005.
22.
ChauN.M., RogersP., AherneW., CarrollV., CollinsI., McDonaldE., WorkmanP., AshcroftM.Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res, 65:4918. 2005.
23.
ShibataT., AkiyamaN., NodaM., SasaiK., HiraokaM.Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int J Radiat Oncol Biol Phys, 42:913. 1998.
24.
YamazakiY., EgawaK., NoseK., KunimotoS., TakeuchiT.HIF-1-dependent VEGF reporter gene assay by a stable transformant of CHO cells. Biol Pharm Bull, 26:417. 2003.
25.
SiddappaR., MartensA., DoornJ., LeusinkA., OlivoC., LichtR., van RijnL., GasparC., FoddeR., JanssenF., van BlitterswijkC., de BoerJ.cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA, 105:7281. 2008.
26.
JanssenF.W., OostraJ., OorschotA., van BlitterswijkC.A.A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials, 27:315. 2006.
27.
PapenburgB.J., VogelaarL., Bolhuis-VersteegL.A., LammertinkR.G., StamatialisD., WesslingM.One-step fabrication of porous micropatterned scaffolds to control cell behavior. Biomaterials, 28:1998. 2007.
28.
AnW.G., KanekalM., SimonM.C., MaltepeE., BlagosklonnyM.V., NeckersL.M.Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature, 392:405. 1998.
29.
KellnerK., LiebschG., KlimantI., WolfbeisO.S., BlunkT., SchulzM.B., GopferichA.Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng, 80:73. 2002.
30.
LewisM.C., MacarthurB.D., MaldaJ., PettetG., PleaseC.P.Heterogeneous proliferation within engineered cartilaginous tissue: the role of oxygen tension. Biotechnol Bioeng, 91:607. 2005.
31.
GuarinoR.D., DikeL.E., HaqT.A., RowleyJ.A., PitnerJ.B., TimminsM.R.Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration. Biotechnol Bioeng, 86:775. 2004.
32.
OlivoC., AlblasJ., VerweijV., van ZonneveldA.J., DhertW.J., MartensA.C.In vivo bioluminescence imaging study to monitor ectopic bone formation by luciferase gene marked mesenchymal stem cells. J Orthop Res, 26:901. 2008.
33.
BrownD.A., MacLellanW.R., LaksH., DunnJ.C., WuB.M., BeyguiR.E.Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Biotechnol Bioeng, 97:962. 2007.
34.
JiangB.H., SemenzaG.L., BauerC., MartiH.H.Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol, 271:C1172. 1996.
35.
RadisicM., DeenW., LangerR., Vunjak-NovakovicG.Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol, 288:H1278. 2005.
36.
KhattakS.F., ChinK.S., BhatiaS.R., RobertsS.C.Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng, 96:156. 2007.
37.
HungS.C., PochampallyR.R., HsuS.C., SanchezC., ChenS.C., SpeesJ., ProckopD.J.Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE, 2:e416. 2007.
38.
InoueY., IzawaK., TojoA., SekineR., OkuboT., OhtomoK.Light emission requires exposure to the atmosphere in ex vivo bioluminescence imaging. Mol Imaging, 5:53. 2006.
39.
MoriyamaE.H., NiedreM.J., JarviM.T., MocanuJ.D., MoriyamaY., SubarskyP., LiB., LilgeL.D., WilsonB.C.The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitro. Photochem Photobiol Sci, 7:675. 2008.
40.
KlerkC.P., OvermeerR.M., NiersT.M., VersteegH.H., RichelD.J., BuckleT., Van NoordenC.J., van TellingenO.Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques, 43,1 Suppl:7. 2007.
